Akari Therapeutics

NASDAQ: AKTX · Real-Time Price · USD
1.00
0.03 (3.08%)
At close: Aug 15, 2025, 3:58 PM
1.00
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT

Akari Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-19.79M -10.01M -17.75M -17.42M
Depreciation & Amortization
14K 4K 3.71K 4.13K
Stock-Based Compensation
2.25M 1.15M 735K 314.65K
Other Working Capital
1.32M 70K -877.11K -1.74M
Other Non-Cash Items
-1.56M -7.65M -5.32M 242.5K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
6.54M 70K 821.89K -1.98M
Operating Cash Flow
-12.55M -16.43M -21.5M -18.85M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
382K n/a n/a n/a
Investing Cash Flow
382K n/a n/a n/a
Debt Repayment
-855K n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
28K 7.02M 94K n/a
Financial Cash Flow
10.99M 7.02M 25.29M 14.29M
Net Cash Flow
-1.19M -9.4M 3.89M -4.69M
Free Cash Flow
-12.55M -16.43M -21.5M -18.85M